PTE - PolarityTE, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
14.59
+0.43 (+3.04%)
As of 9:34AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close14.16
Open14.17
Bid14.16 x 1300
Ask14.87 x 1000
Day's Range14.17 - 14.66
52 Week Range2.56 - 1,461.24
Volume10,873
Avg. Volume155,278
Market Cap308.247M
Beta (3Y Monthly)0.85
PE Ratio (TTM)N/A
EPS (TTM)-5.39
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2016-01-12
1y Target Est65.00
Trade prices are not sourced from all markets
  • Moving Average Crossover Alert: PolarityTE (PTE)
    Zacks3 days ago

    Moving Average Crossover Alert: PolarityTE (PTE)

    PolarityTE, Inc. (PTE) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

  • Benzinga6 days ago

    Cool Mara Riot, Part Two: Securities-Fraud Case Against South Florida Group Reverberates Through Additional Companies

    EDITOR'S NOTE: The following is an excerpt of part two of an investigation into financier Barry Honig and several associated parties. When financier Barry C. Honig was waging a proxy fight for control of the company that became Riot Blockchain Inc. (NASDAQ: RIOT), he demanded that it return excess capital to shareholders through a special dividend.

  • PolarityTE® Announces Reporting of Apparent Intentional Market Manipulation by Third Parties to Regulatory Authorities
    PR Newswire6 days ago

    PolarityTE® Announces Reporting of Apparent Intentional Market Manipulation by Third Parties to Regulatory Authorities

    SALT LAKE CITY, Oct. 9, 2018 /PRNewswire/ -- PolarityTE, Inc. (PTE) announced that multiple regulatory bodies are being notified of suspected significant illegal trading in the Company's securities. After this information was brought to the Company's attention, the Financial Industry Regulatory Authority (FINRA) was notified.

  • PolarityTE® to Present at the DFCon 2018 Diabetic Foot Global Conference on Clinical Outcomes Associated with SkinTE™
    PR Newswire10 days ago

    PolarityTE® to Present at the DFCon 2018 Diabetic Foot Global Conference on Clinical Outcomes Associated with SkinTE™

    SALT LAKE CITY, Oct. 5, 2018 /PRNewswire/ -- PolarityTE, Inc. (PTE) announced that the Company will be presenting on its SkinTE technology and clinical outcomes at the 18th annual DFCon Diabetic Foot Global Conference on Thursday, October 11, 2018 in Houston, TX. DFCon is the premier international, interdisciplinary diabetic foot conference in North America. In its 18th year, the course is designed for the wide spectrum of generalists and specialists who diagnose and manage the diabetic foot.

  • PolarityTE Announces the Expansion of the Sales Team in the Regional Market Release of SkinTE™
    PR Newswire19 days ago

    PolarityTE Announces the Expansion of the Sales Team in the Regional Market Release of SkinTE™

    SALT LAKE CITY, Sept. 26, 2018 /PRNewswire/ -- PolarityTE, Inc. (PTE) today announced the successful recruitment of sales directors in key major metropolitan markets who will facilitate the second phase of the regional market rollout of SkinTE. SkinTE is a human cellular and tissue-based product derived from a patient's own skin intended for the repair, reconstruction, and replacement of skin tissue. SkinTE results have shown the regeneration of full-thickness (epidermis, dermis, and hypodermis), functionally-polarized skin with all the appendages including hair and glands.

  • PolarityTE Announces Presentations of SkinTE Clinical Results at Upcoming Plastic Surgery Conferences
    PR Newswire21 days ago

    PolarityTE Announces Presentations of SkinTE Clinical Results at Upcoming Plastic Surgery Conferences

    SALT LAKE CITY, Sept. 24, 2018 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) today announced that SkinTE™ clinical results will be presented at the American Society of Plastic Surgeons (ASPS) Plastic Surgery The Meeting and the International Society of Plastic Regenerative Surgeons (ISPRES) Congress, both held in Chicago the weekend of September 28, 2018. SkinTE is a human cellular and tissue-based product derived from a patient's own skin intended for the repair, reconstruction, and replacement of skin tissue. SkinTE results have shown the regeneration of full-thickness (epidermis, dermis and hypodermis), functionally-polarized skin with all the appendages including hair and glands.

  • PolarityTE to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference
    PR Newswire25 days ago

    PolarityTE to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference

    SALT LAKE CITY, Sept. 20, 2018 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products for the fields of medicine, biomedical engineering and material sciences, today announced it will attend and present at the 2018 Cantor Fitzgerald Global Healthcare Conference on Monday, October 1, 2018. PolarityTE is a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences.

  • Should Parcel Technik SA.’s (WSE:PTE) Recent Earnings Decline Worry You?
    Simply Wall St.7 months ago

    Should Parcel Technik SA.’s (WSE:PTE) Recent Earnings Decline Worry You?

    Examining Parcel Technik SA.’s (WSE:PTE) past track record of performance is a useful exercise for investors. It allows us to reflect on whether the company has met or exceed expectations,Read More...